CD8 T Cell Replicative Senescence: Impact on Aged Humans
CD8 T Cell Replicative Senescence: Impact on Aged Humans
批准号:
7013101
负责人:
RITA BRICKMAN EFFROS
金额:
$29.92万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-15 至 2010-01-31
关键词:
CD28 moleculeagingantibody formationbone metabolismcell cell interactioncell differentiationcell senescenceclinical researchcytotoxic T lymphocytedisease /disorder modelestrogensgenetic transductionhelper T lymphocytehuman subjectimmunopathologyimmunoregulationimmunosenescenceimmunotherapylaboratory mouseosteoblastsosteoclastsosteoporosisoxidative stresspathologic processtelomerasetherapy design /developmenttissue /cell culture
中文摘要
描述(由申请人提供):拟议的研究解决了一系列问题,这些问题来自老年人在其一生中暴露于无数病原体的事实。在某些情况下,这种免疫史导致产生已达到复制性衰老阶段的记忆性CD 8 T细胞的扩增群体。在细胞培养中,与其CD 28+祖细胞相比,在重复轮抗原驱动的增殖后达到这种状态的CD 8 T细胞显示出不可逆的细胞周期停滞、CD 28基因表达的永久丧失、凋亡抗性、对应激的不良反应、改变的细胞因子谱和缩短的端粒。临床研究已经确定了显示复制性衰老特征的CD 8 T细胞与诸如对流感疫苗接种的反应性降低和骨质疏松性骨折等多种健康结果之间的相关性。这项研究的中心假设是,体内存在的高比例衰老CD 8 T细胞在衰老过程中对免疫和非免疫器官系统产生有害影响。为了进一步阐明CD 8 T细胞复制性衰老介导多效性生理效应的潜在机制,将致力于以下具体目标:(1)确定衰老的CD 8 T细胞对免疫功能的作用。将评价直接细胞相互作用和来自衰老培养物的无细胞上清液对CD 4 T细胞辅助、CD 8效应子功能、抗原呈递和抗体产生的影响。(2)评估逆转CD 8 T细胞复制性衰老的遗传和非遗传操作。将比较含有CD 28或端粒酶的慢病毒载体、降低的氧水平和暴露于雌激素(其影响与衰老相关的几个基因)对端粒/端粒酶动力学、群体倍增、CD 8 T细胞免疫功能和目标1中鉴定的免疫调节功能的影响。(3)基于慢性免疫激活对骨完整性的充分记录效应和骨髓中产生精氨酸的T细胞的鉴定,研究衰老的CD 8 T细胞在骨质疏松症中的作用。将比较早期传代和衰老的CD 8 T细胞对破骨细胞(骨吸收细胞)和成骨细胞(骨形成细胞)的成熟、分化和功能的影响。将使用骨质疏松症鼠模型确认体外观察结果。总之,拟议的研究将提供一个无与伦比的机会,以实验方式剖析人类免疫衰老的几个基本方面的遗传和分子基础,这些方面显著影响健康和寿命。
英文摘要
DESCRIPTION (provided by applicant): The proposed research addresses a series of questions that emerge from the fact that elderly persons have been exposed to a myriad of pathogens over their lifespan. This immunological history leads, in some cases, to the generation of expanded populations of memory CD8 T cells that have reached the stage of replicative senescence. In cell culture, CD8 T cells that reach this state after repeated rounds of antigen-driven proliferation show irreversible cell cycle arrest, permanent loss of CD28 gene expression, apoptosis resistance, poor response to stress, altered cytokine profiles, and shortened telomeres compared to their CD28+ progenitors. Clinical studies have identified correlations between CD8 T cells showing characteristics of replicative senescence and such diverse health outcomes as reduced responsiveness to influenza vaccination and osteoporotic fractures. The central hypothesis of the proposed research is that the high proportion of senescent CD8 T cells present in vivo exerts deleterious effects on both immune and non-immune organ systems during aging. To further elucidate the underlying mechanisms by which CD8 T cell replicative senescence may mediate pleiotropic physiological effects, the following specific aims will be addressed: (1) To determine the role of senescent CD8 T cells on immune function. Direct cell interaction and cell-free supernatants from senescent cultures will be evaluated for their impact on CD4 T cell help, CD8 effector functions, antigen-presentation and antibody production. (2) To evaluate genetic and non-genetic manipulations to reverse CD8 T cell replicative senescence. Lentivirus vectors containing CD28 or telomerase, reduced levels of oxygen, and exposure to estrogen (which affects several genes associated with senescence) will be compared for effects on telomere/telomerase dynamics, population doublings, CD8 T cell immune functions, and immune modulatory functions identified in Aim 1. (3) To investigate the role of senescent CD8 T cells in osteoporosis, based on the well-documented effects of chronic immune activation on bone integrity and on the identification of cytokine-producing T cells within the bone marrow. Early passage and senescent CD8 T cells will be compared for effects on the maturation, differentiation, and function of osteoclasts (the bone resorbing cells) and osteoblasts (the bone forming cells). In vitro observations will be confirmed using a murine model of osteoporosis. In sum, the proposed studies will provide an unparalleled opportunity to experimentally dissect the genetic and molecular basis of several fundamental aspects of human immunological aging that significantly impact health and longevity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The mucosal immune system: effects of aging and chronic antigenic stimulation
-
批准号:8132260
-
项目类别:
-
资助金额:$100.86万
-
财政年份:2009
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
The mucosal immune system: effects of aging and chronic antigenic stimulation
-
批准号:7656845
-
项目类别:
-
资助金额:$102.65万
-
财政年份:2009
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
The mucosal immune system: effects of aging and chronic antigenic stimulation
-
批准号:8309195
-
项目类别:
-
资助金额:$99.34万
-
财政年份:2009
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
The mucosal immune system: effects of aging and chronic antigenic stimulation
-
批准号:8528435
-
项目类别:
-
资助金额:$92.65万
-
财政年份:2009
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
The mucosal immune system: effects of aging and chronic antigenic stimulation
-
批准号:7934563
-
项目类别:
-
资助金额:$103.26万
-
财政年份:2009
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
Conference on the Biology of Aging
-
批准号:7331370
-
项目类别:
-
资助金额:$3.92万
-
财政年份:2007
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence: Impact on Aged Humans
-
批准号:7189082
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2005
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence: Impact on Aged Humans
-
批准号:7777093
-
项目类别:
-
资助金额:$5.66万
-
财政年份:2005
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence: Impact on Aged Humans
-
批准号:7842087
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2005
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence: Impact on Aged Humans
-
批准号:7386587
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2005
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence: Impact on Aged Humans
-
批准号:7576720
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2005
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence: Impact on Aged Humans
-
批准号:6866963
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2005
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Interaction with Bone Cells in HIV Disease
-
批准号:6839860
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence & HIV Disease
-
批准号:7033896
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence & HIV Disease
-
批准号:6798392
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
T Cell Replicative Senescence & Bone Loss During Aging
-
批准号:6933063
-
项目类别:
-
资助金额:$15.64万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence & HIV Disease
-
批准号:7212267
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
T Cell Replicative Senescence & Bone Loss During Aging
-
批准号:6807536
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Interaction with Bone Cells in HIV Disease
-
批准号:6899200
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
CD8 T Cell Replicative Senescence & HIV Disease
-
批准号:7385978
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2004
-
负责人:RITA BRICKMAN EFFROS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: